R
R. Tam
Researcher at California Institute of Technology
Publications - 3
Citations - 12128
R. Tam is an academic researcher from California Institute of Technology. The author has contributed to research in topics: Fusion protein & Antibody. The author has an hindex of 2, co-authored 2 publications receiving 11221 citations.
Papers
More filters
Journal ArticleDOI
The Two Micron All Sky Survey (2MASS)
Michael F. Skrutskie,Michael F. Skrutskie,Roc M. Cutri,R. Stiening,Martin D. Weinberg,Stephen E. Schneider,John M. Carpenter,Chas Beichman,R. Capps,T. Chester,J. Elias,John P. Huchra,James Liebert,C. Lonsdale,David G. Monet,Stephan D. Price,Patrick Seitzer,Thomas H. Jarrett,J. D. Kirkpatrick,John E. Gizis,E. Howard,T. Evans,John W. Fowler,L. Fullmer,Robert L. Hurt,R. M. Light,E. L. Kopan,K. A. Marsh,H. McCallon,R. Tam,S. D. Van Dyk,S. Wheelock +31 more
TL;DR: The Two Micron All Sky Survey (2MASS) as mentioned in this paper collected 25.4 Tbytes of raw imaging data from two dedicated 1.3 m diameter telescopes located at Mount Hopkins, Arizona and CerroTololo, Chile.
VizieR Online Data Catalog: The 2MASS Extended sources (IPAC/UMass, 2003-2006)
M. F. Skrutskie,R. M. Cutri,R. Stiening,Martin D. Weinberg,Stephen E. Schneider,John M. Carpenter,C. A. Beichman,R. Capps,T. Chester,J. Elias,John P. Huchra,J. Liebert,C. Lonsdale,David G. Monet,Stephan D. Price,Patrick Seitzer,Thomas H. Jarrett,J. D. Kirkpatrick,John E. Gizis,E. Howard,Timothy Evans,John W. Fowler,L. Fullmer,Robert L. Hurt,R. M. Light,E. L. Kopan,K. A. Marsh,L. H. McCallon,R. Tam,S. D. Van Dyk,S. Wheelock +30 more
Journal ArticleDOI
Abstract 4223: Cis-activation of PD-1+ effector T cells with dual-targeting immunocytokines generated using a novel chemical conjugation platform
Jean-Philippe Carralot,Matilde Ruiz,R. Tam,Eric Armentani,Vijaya R. Pattabiraman,Bertolt Kreft +5 more
TL;DR: Carralot et al. as mentioned in this paper developed an approach based on the site-specific, chemical conjugation of synthetic cytokines to antibodies, which can then be readily chemically conjugated to specific lysine residues in the Fc region of an existing IgG1, IgG2 or IgG4 antibody.